Lack of neuropeptide Y receptor detection in human bladder and prostate

BJU International

Volumn 85, Issue 7, 2000, Pages 918-924

  Davis, B ^e   Goepel, M ^a,b   Bein, S ^a,b   Chess Williams, R ^e   Chapple, C R ^e   Michel, Martin C ^a,b,c,d  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF DUISBURG ESSEN   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY HOSPITAL ESSEN   (Germany)

^e NONE

Author keywords

Bladder; Human; Neuropeptide Y; Prostate; Receptor

Indexed keywords

CARBACHOL; IODINE 125; NEUROPEPTIDE Y RECEPTOR; NORADRENALIN; PEPTIDE YY; RADIOLIGAND;

ANIMAL TISSUE; ARTICLE; BLADDER; BLADDER CONTRACTION; BRAIN CORTEX; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOMOGENATE; HUMAN; HUMAN TISSUE; MALE; MUSCLE CONTRACTION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROSTATE; RAT; STIMULATION; TISSUE CULTURE; VAS DEFERENS;

ANIMALS; BINDING, COMPETITIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HUMANS; MALE; MUSCLE CONTRACTION; NERVE FIBERS; PROSTATE; RATS; RATS, WISTAR; RECEPTORS, NEUROPEPTIDE Y; URINARY BLADDER;

EID: 0034091731     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00573.x     Document Type: Article

References (29)

1. 1 Sundler F, Bötteher G, Ekblad E, Hakanson R. PP, PYY and NPY. Occurence and distribution in the periphery. In Colmers WF, Wahlestedt C, eds. The Biology of Neuropeptide Y and Related Peptides. Totowa NJ: Humana Press, Inc., 1993: 157-96
2. 2 Smet PJ, Edyvane KA, Jonavicius J, Marshall VR. Colocalization of nitric oxide synthase with vasoactive intestinal peptide, neuropeptide Y, and tyrosine hydroxylase in nerves supplying the human ureter. J Urol 1994; 152: 1292-6
3. 3 Crowe R, Noble J, Robson T, Soediono P, Milroy EJG. Burnstock G. An increase of neuropeptide Y but not nitric oxide synthase-immunoreactive nerves in the bladder neck from male patients with bladder neck dyssynergia. J Urol 1995; 154: 1231-6
4. 4 Edyvane KA, Smet PJ, Jonavicius J, Marshall VR. Regional differences in the innervation of the human ureterovesical junction by tyrosine hydroxylase-, vasoactive intestinal peptide-and neuropeptide Y-like immunoreactive nerves. J Urol 1995; 154: 262-6
5. 5 Chapple CR, Crowe R, Gilpin SA, Gosling J, Burnstock G. The innervation of the human prostate gland - the changes associated with benign enlargement. J Urol 1991; 146: 1637-44
6. 6 Crowe R, Chapple CR, Burnstock G. The human prostate gland: a histochemical and immunohistochemical study of neuropeptides, serotonin, dopamine β-hydroxylase and acetylcholinesterase in autonomic nerves and ganglia. Br J Urol 1991; 68: 53-61
7. 7 Tainio H. Peptidergic innervation of the human prostate, seminal vesicle and vas deferens. Acta Histochem 1997; 97: 113-9
8. 8 Edvinsson L, Hakanson R, Wahlestedt C, Uddman R. Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol Sci 1987; 8: 231-5
9. 9 Michel MC, Rascher W, Neuropeptide Y - a possible role in hypertension? J Hypertension 1995; 13: 385-95
10. 10 Prieto D, Hernandez M, Rivera L, Garcia-Sacristan A, Simonsen U. Distribution and functional effects of neuropeptide Y on equine ureteral smooth muscle and resistance arteries. Regul Pept 1997; 69: 155-65
11. 11 Zoubek J, Somogyi GT, De Groat WC. A comparison of inhibitory effects of neuropeptide Y on rat urinary bladder, urethra, and vas deferens. Am J Physiol 1993; 265: R537-R543
12. 12 Irie K, Ohike N, Muraki T, Furukawa K, Nomoto T. Contractile response to neuropeptide Y of rat isolated duodenum. Peptides 1993; 14: 601-5
13. 13 Michel MC, Beck-Sickinger AG, Cox H et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY and pancreatic polypeptide receptors. Pharmacol Rev 1998; 50: 143-50
14. 1 receptor/ G-protein system in rat brain cortex. Am J Physiol 1995; 268: R192-R200
15. 1-adrenoceptor. Br J Pharmacol 1996; 119: 1093-100
16. 16 Martin SW, Radley SC, Chess-Williams R, Korstanje C, Chappie CR. Relaxant effects of potassium channel openers on normal and hyper-reflexic detrusor muscle. Br J Urol 1997; 80: 405-13
17. 17 Grandt D, Schimiczek M, Rascher W et al. Neuropeptide Y 3-36 is an endogenous ligand selective for Y2 receptors. Regul Pept 1996; 67: 33-7
18. 18 Bischoff A, Michel MC. Renal effects of neuropeptide Y. Pflügers Arch 1998; 435: 443-53
19. 19 Wharton J, Gordon L, Byrne J et al. Expression of the human neuropeptide tyrosine Y1 receptor. Proc Natl Acad Sci USA 1993; 90: 687-91
20. 20 Rump LC, Riess M, Schwertfeger E, Michel MC, Bohmann C, Schollmeyer P. Prejunctional neuropeptide Y receptors in human kidney and atrium. J Cardiovasc Pharmacol 1997; 29: 656-61
21. 21 Lundell I, Blomquist AC, Berglund MM et al. Cloning of a human receptor of the NPY receptor family with high affinity for pancreatic polypeptide and peptide YY. J Biol Chem 1995; 270: 29123-8
22. 22 Matsumoto M, Nomura T, Momose K et al. Inactivation of a novel neuropeptide Y/peptide YY receptor gene in primate species. J Biol Chem 1996; 271: 27217-20
23. 23 Sjögren C, Anderssein K-E, Andersson P-O, Muttiasson A, Uvelius B. Different effects of neuropeptide Y on electrically induced contractions in the longitudinal and circular smooth muscle layers of the female rabbit urethra. Acta Physiol Scand 1988; 133: 177-81
24. 24 Watts SW, Cohen ML. Effect of bombesin, bradykinin. substance P and CGRP in prostate, bladder body and neck. Peptides 1991; 12: 1057-62
25. 25 Solano RM, Carmena MJ, Guijarro LG, Prieto JC. Neuropeptide Y inhibits vasoactive intestinal peptide-stimulated adenylyl cyclase in rat ventral prostate. Neuropeptides 1994; 27: 31-7
26. 26 Kopp J, Zhang X, Hökfelt T. Neuropeptide Y1 receptors in the rat genital tract. Regul Pept 1997; 70: 149-60
27. 27 Caine M, Raz S, Zeigler M. Adrenergic and cholinergic receptors in the human prostate, prostatic capsule and bladder neck. Br J Urol 1975; 47: 193-202
28. 28 Michel MC, Gaida W, Beek-Sickinger AG et al. Further characterization of neuropeptide Y receptor subtypes using centrally truncated analogs of neuropeptide Y. Evidence for subtype-differentiating effects on affinity and intrinsic efficacy. Mol Pharmacol 1992; 42: 642-8
29. 29 Price JS, Kenny AJ, Huskisson NS, Brown MJ. Neuropeptide Y (NPY) metabolism by endopeptidase-2 hinders characterization of NPY receptors in rat kidney. Br J Pharmacol 1991; 104: 521-6